| 000 | 01606 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517225328.0 | ||
| 264 | 0 | _c20190910 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1524-4539 | ||
| 024 | 7 |
_a10.1161/CIRCULATIONAHA.117.031982 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCarroll, Margaret D | |
| 245 | 0 | 0 |
_aTrends in Apolipoprotein B, Non-High-Density Lipoprotein, and Low-Density Lipoprotein for Adults 60 Years and Older by Use of Lipid-Lowering Medications: United States, 2005 to 2006 Through 2013 to 2014. _h[electronic resource] |
| 260 |
_bCirculation _c07 2018 |
||
| 300 |
_a208-210 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aApolipoproteins B _xblood |
| 650 | 0 | 4 |
_aAtherosclerosis _xdiagnosis |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLipid Metabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aMussolino, Michael E | |
| 700 | 1 | _aWolz, Michael | |
| 700 | 1 | _aSrinivas, Pothur R | |
| 773 | 0 |
_tCirculation _gvol. 138 _gno. 2 _gp. 208-210 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/CIRCULATIONAHA.117.031982 _zAvailable from publisher's website |
| 999 |
_c28613006 _d28613006 |
||